Abstract: Poster Presentations |


Sanjeev Sinha, MD*; S. K. Sharma, MD; N. Kumar, MSc; Naimish R. Patel, MD
Author and Funding Information

AIIMS, New Delhi, India


Chest. 2008;134(4_MeetingAbstracts):p132001. doi:10.1378/chest.134.4_MeetingAbstracts.p132001
Text Size: A A A
Published online


PURPOSE: Mycobacterium tuberculosis (MTb) infection remains a serious global lung health problem where morbidity and mortality associated with MTb is especially high in persons co-infected with HIV. Alveolar macrophages (AMs) are primary effector cells of lung innate immunity and critical cells in the host response to MTb. Recent study has revealed that vitamin D plays an important role in AM clearance of MTb. We proposed in this study that altered vitamin D levels may play a role in increasing susceptibility to MTb with HIV+ and HIV (-) individuals.

METHODS: We obtained discarded clinical samples from bronchoscopies performed on the HIV+ and HIV (-) individuals with and without MTb disease. We also obtained concurrent serum samples of these individuals. The levels of 25-OH Vitamin D was measured in serum and bronchoalveolar lavage fluid (BAL) according to manufacturer's protocol with a standard ELISA kit (IDS Ltd., Fountain Hills, AZ). Ratio of urea concentration of BAL fluid to serum urea concentration was used as the BAL dilution factor.

RESULTS: We have enrolled 12 patients in each group. The serum levels of 25-OH Vitamin D in HIV (-) individuals with MTb disease was low (37.18 nmol/L) as compared to HIV (-) individuals without MTb disease (54.95 nmol/L). Similarly the BAL fluid levels of 25-OH Vitamin D in HIV (-) individuals with MTb disease was low (12.15 nmol/L) as compared to HIV (-) individuals without MTb disease (14.0 nmol/L).

CONCLUSION: This initial pilot study will allow us to determine if there is a possible relation to vitamin D levels and the presence of MTb disease.

CLINICAL IMPLICATIONS: This work will lead to important findings in the pathogenesis of MTb infection and may also reveal specific targets (use of Vitamin D supplementation) that can be used in the future as the basis for treatment and prevention of disease.

DISCLOSURE: Sanjeev Sinha, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

1:00 PM - 2:15 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543